SIGN UP
LOG IN
A
ACON
Aclarion Inc
7.34
0.01+0.07%After Hours: 7.07 -0.27 -3.61%19:16 07/15 EDT
OPEN/PREV CLOSE7.07/7.33
TODAY RANGE7.07-7.34
VOL8.51K
MARKET CAP4.27M
52 WEEK RANGE6.20-3,499.51
AVG VOL (3M)21.88K
% TURNOVER1.46%
TURNOVER--
P/E (TTM)-0.0017
% RANGE3.62%
EPS(TTM)-4,364.9156
P/E(FORWARD)-0.5202
P/B0.2707
BVPS27.10
DIVIDEND--
P/S0.2198
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.27M
SHARES OUTSTANDING582.37K
NEXT EARNINGS--
FREE FLOAT582.35K
LOT SIZE1
EX-DATE03/28/2025
News
Press Releases
Financial Reports
Profile
TipRanks·07/07 20:51
Aclarion, Inc. Adjourns Annual Meeting to Solicit Votes
TipRanks·06/25 10:05
Aclarion announces first patient enrolled in Clarity trial
Reuters·06/25 10:00
ACLARION INC - ACCLARION EXPECTS CLARITY INTERIM RESULTS IN Q2 2026
Barchart·06/25 05:00
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
TipRanks·06/24 11:10
Aclarion to present NOCISCAN at State of Spine Surgery Think Tank
Dow Jones·06/20 21:16
*Aclarion CFO John Lorbiecki to Retire, Will Remain With Company Over Several Months
Reuters·06/20 21:09
ACLARION INC - EXPECTS TO APPOINT NEW CFO BY Q3 2025 - SEC FILING
TipRanks·06/10 10:20
Aclarion adds UHealth, University of Miami as trial site for Nociscan
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.